NCT03342456 - The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers | Biotech Hunter

Enrollment

184

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

June 20, 2019

Study Completion Date

September 20, 2019

Conditions

Duodenal Ulcer Due to Helicobacter Pylori

Interventions

DRUG

Doxycycline Hyclate Enteric-Coated Capsules

group 1,0.1g\*10 capsules/box, produced by Yung Shin Pharm.Ind.(Kunshan) Co.,Ltd.

DRUG

Amoxicillin Capsules

group 2,0.5g\*24 capsules/box, produced by United Laboratories（Zhuhai）

DRUG

Ilaprazole Enteric-Coated Tablets

group 1 and group 2,5mg\*6 capsules/box, produced by Livzon Pharmaceutical Group Inc

DRUG

Furazolidone Tablets

group 1 and group 2,0.1g\*100 tablets/bottle,produced by Shanxi Yunpeng Pharmaceutical co.,Ltd.

DRUG

Potassium Citrate Tablets

group 1 and group 2,110mg\*40 tablets/bottle,produced by Livzon Pharmaceutical Group Inc

Trial Locations (7)

Xiangya Hospital of Central South University, Changsha

The Second Xiangya Hospital of Central South University, Changsha

The Third Xiangya Hospital of Central South University, Changsha

Loudi central hospital, Loudi

The First Affiliated Hospital of University of South China, Hengyang

Shaoyang Central Hospital, Shaoyang

The Affiliated Hospital Of YongZhou Vocational Technical College, Yongzhou